Lunch n' Learn with RIPA
This June!
The Rhode Island Pharmacists Association
is excited to OPEN registration for the 1st of TWO Virtual CE Programs
Wednesday, June 5th 2024
12:00 PM - 1:00 PM
Location: Zoom link to be provided within 24 hours of program
In order to receive complimentary registration for pharmacist and technician members, registration and membership dues must be received before June 5th
Not a member? Join prior to the registration to obtain complimentary attendance to the program!
This is a locally sponsored educational event that will give you a chance to get obtain 1 credit (0.1 CEU) of LIVE CE
Exhibitor or Sponsorship Opportunities:
Please email the following for more info:
Email: Info@ripharmacists.org
Click HERE to also register for the June 6th Lunch n' Learn with Suzanne Bornschein MD, FACP
**A computer or mobile device with an internet connection – broadband wired or wireless (3G or 4G/LTE).
It is recommended to download the Zoom app (no account sign-up required) before joining the conference.**
Presenter: Kat Houlihan, PharmD
Title: "Spray It Forward: Educating Pharmacy Teams on OTC Naloxone Nasal Spray"
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is an application-based educational activity. Pharmacists will receive 1.0 contact hour (0.10 CEUs) for the educational activity. No partial credit is available.
UNIVERSAL ACTIVITY NUMBER (UAN)
Pharmacists UAN: 0060-9999-24-027-L08-P
Pharmacy Technicians UAN: 0060-9999-24-027-L08-T
Learning Objectives
At the completion of this activity, pharmacists will be able to:
1. Describe the role of OTC naloxone in the acute treatment of opioid overdose
2. Analyze the results of a community pharmacy-based survey on the OTC status of naloxone
3. Evaluate the gaps in knowledge surrounding OTC naloxone.
4. Identify strategies to improve accessibility and attitudes towards OTC naloxone
At the completion of this activity, pharmacy technicians will be able to:
1. Describe the role of OTC naloxone in the acute treatment of opioid overdose
2. Analyze the results of a community pharmacy based survey on the OTC status of naloxone
3. Evaluate the effect of product placement on accessibility to this product
4. Identify strategies to improve accessibility and attitudes towards OTC naloxone
REQUIREMENTS FOR REPORTING CE: Participants must login to the URI Continuing Professional Development Learning Management System at https://www.uripharmacycpd.org/ to complete evaluations and report ce participant data within 60 days following the live activity. Access codes will be given at the conclusion of the learning activity; learners must be present for the full session to receive the online evaluation access code and receive credit. Upon successful completion of the online program evaluation, cpe participant data will be automatically uploaded to the CPE Monitor and posted to the participant’s account within 72 hours. Participants should verify their CE data was successfully transmitted to the CPE Monitor at mycpemonitor.net.
